SCHEMBL658639

SCHEMBL658639

CS(=O)(=O)NNC(=O)C1=CN(CC(=O)c2ccc(Br)cc2)C=CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
MAPT P10636 3/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 2/20 0.33
GSK3B P49841 2/20 0.33
HTT P42858 1/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33
KAT6A Q92794 2/20 0.33
CXCR3 P49682 2/20 0.33
MGAM O43451 1/20 0.33
AMY1A P0DUB6 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
HAO1 Q9UJM8 1/20 0.33
HDAC3 O15379 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660526 0.89 KAT6A (0.35) ALDH1A1MAPTGAASMN1; SMN2RAB9A
SCHEMBL297855 0.87 ALDH1A1 (0.42) ALDH1A1MAPTGAAGSK3BHTT
SCHEMBL27854975 0.79 ALDH1A1 (0.37) ALDH1A1MAPTGAASMN1; SMN2RAB9A
SCHEMBL661083 0.79 ALDH1A1 (0.39) ALDH1A1MAPTLMNAMAPK1KMT2A
SCHEMBL659354 0.79 ALDH1A1 (0.33) ALDH1A1MAPTGAASMN1; SMN2RAB9A
SCHEMBL659968 0.79 TSHR (0.37) ALDH1A1MAPTGAASMN1; SMN2RAB9A
SCHEMBL662691 0.78 KMT2A (0.37) ALDH1A1MAPTGAASMN1; SMN2GSK3B
SCHEMBL660454 0.77 KAT6A (0.51) ALDH1A1MAPTGAACYP3A4KAT6A
SCHEMBL661709 0.76 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2RAB9AHTTLMNA
SCHEMBL298474 0.76 SMN1; SMN2 (0.40) ALDH1A1MAPTGAASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT ALDH1A1 676/4885MAPT 61/4885GAA 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.